1.0779
26-نوفمبر-24 12:11:19
15 متأخرة بدقائق
الأسهم
-0.0221
-2.01%
نطاق اليوم
1.0400 - 1.1143
ISIN
N/A
المصدر
NASDAQ
Ocuphire to Participate in the 2021 BIO CEO & Investor Conference and Cantor Fitzgerald’s Panel on Eyeing Key Events in the Ophthalmology Space in 2021
11 فبراير 2021 08:12:54 بحسب Nasdaq GlobeNewswire
Ocuphire Announces Publication of ORION-1 Phase 2 Results for Nyxol in Clinical Ophthalmology and Presentation at the January OIS Presbyopia Innovation Showcase
20 يناير 2021 06:00:00 بحسب Nasdaq GlobeNewswire
Ocuphire Completes Enrollment in MIRA-2 Phase 3 Clinical Trial Investigating Nyxol® for Reversal of Mydriasis
06 يناير 2021 06:00:01 بحسب Nasdaq GlobeNewswire